UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030022
Receipt number R000033002
Scientific Title A novel metallic stent for unresectable distal malignant biliary obstruction; A multicenter prospective study
Date of disclosure of the study information 2017/11/17
Last modified on 2022/05/13 11:12:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A novel metallic stent for unresectable distal malignant biliary obstruction; A multicenter prospective study

Acronym

EVOLUTION study

Scientific Title

A novel metallic stent for unresectable distal malignant biliary obstruction; A multicenter prospective study

Scientific Title:Acronym

EVOLUTION study

Region

Japan


Condition

Condition

Unresectable distal malignant biliary obstruction

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of novel full covered metal stent for unresectable malignant distal biliary obstruction.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Stent patency

Key secondary outcomes

Technical success, Clinical success, Complications, Stent replaced, Survival period


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Full covered self expandable metal stent

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients with unresectable malignant biliary stricture diagnosed by pathological findings.
(2) Patients with written informed consent.

Key exclusion criteria

(1) Patients with uncontrolable jaundice or cholangitis after biliary drainage.
(2) Patients with serious comorbidities.
(3) Patients with ECOG performance status 4.
(4) Patients with not expected prognosis more than 3 months.
(5) Patients with hilar biliary stricture.
(6) Patients with biliary reconstruction.
(7) Patients with considered ineligible by the attending physician.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name Atsuhiro
Middle name
Last name Masuda

Organization

Kobe University Graduate School of Medicine

Division name

Division of gastroenterology, Department of Internal medicine

Zip code

650-0017

Address

7-5-1, Kusunoki-cho, Chuo-ku, Kobe, Japan

TEL

078-382-6305

Email

atmasuda@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Arata
Middle name
Last name Sakai

Organization

Kobe University Graduate School of Medicine

Division name

Division of gastroenterology, Department of Internal medicine

Zip code

650-0017

Address

7-5-1, Kusunoki-cho, Chuo-ku, Kobe, Japan

TEL

078-382-6305

Homepage URL


Email

asakai@med.kobe-u.ac.jp


Sponsor or person

Institute

Division of gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe Univ. Hosp. clinical and translational research center

Address

7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Japan

Tel

078-382-6669

Email

kainyu@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

73

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 01 Month 25 Day

Date of IRB

2018 Year 03 Month 07 Day

Anticipated trial start date

2018 Year 03 Month 16 Day

Last follow-up date

2020 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2020 Year 11 Month 20 Day

Date analysis concluded

2022 Year 01 Month 24 Day


Other

Other related information



Management information

Registered date

2017 Year 11 Month 17 Day

Last modified on

2022 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033002


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name